Back to Search Start Over

The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis

Authors :
Rhiannon Morris
Liesl Butler
Andrew Perkins
Nadia J. Kershaw
Jeffrey J. Babon
Source :
Pharmaceuticals, Vol 15, Iss 1, p 24 (2021)
Publication Year :
2021
Publisher :
MDPI AG, 2021.

Abstract

LNK is a member of the SH2B family of adaptor proteins and is a non-redundant regulator of cytokine signalling. Cytokines are secreted intercellular messengers that bind to specific receptors on the surface of target cells to activate the Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) signalling pathway. Activation of the JAK-STAT pathway leads to proliferative and often inflammatory effects, and so the amplitude and duration of signalling are tightly controlled. LNK binds phosphotyrosine residues to signalling proteins downstream of cytokines and constrains JAK-STAT signalling. Mutations in LNK have been identified in a range of haematological and inflammatory diseases due to increased signalling following the loss of LNK function. Here, we review the regulation of JAK-STAT signalling via the adaptor protein LNK and discuss the role of LNK in haematological diseases.

Details

Language :
English
ISSN :
14248247
Volume :
15
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Pharmaceuticals
Publication Type :
Academic Journal
Accession number :
edsdoj.8967ef01c26442b3a3b73b4d0a38c900
Document Type :
article
Full Text :
https://doi.org/10.3390/ph15010024